Cancer-focused Alligator Bioscience is clamping down on costs, laying off 70% of its team in efforts to save around $6 million every year. The Swedish biotech is “sharpening its primary focus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback